Protara Therapeutics (TARA)
(Delayed Data from NSDQ)
$3.11 USD
-0.04 (-1.27%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $3.12 +0.01 (0.32%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Protara Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TARA 3.11 -0.04(-1.27%)
Will TARA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TARA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TARA
Protara Therapeutics (TARA) Moves to Buy: Rationale Behind the Upgrade
TARA Stock Soars on Superior Efficacy of Bladder Cancer Cell Therapy
TARA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TARA
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ...
Catalio Capital Management Raises Over $400M to Invest in Innovative Healthcare Companies in ...
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ...
Protara Therapeutics (TARA) Added to Russell 3000 Index
Protara Therapeutics added to the Russell 3000 index